Spontaneous Fusion with Transformed Mesenchymal Stromal Cells Results in Complete Heterogeneity in Prostate Cancer Cells

Author:

Wang Ruoxiang1ORCID,Hu Peizhen1,Wang Fubo1,Lyu Ji1,Ou Yan2,Edderkaoui Mouad1ORCID,Zhang Yi2,Lewis Michael S.3ORCID,Pandol Stephen J.1ORCID,Zhau Haiyen E.1,Chung Leland W. K.1

Affiliation:

1. Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

2. Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

3. Department of Medicine and Pathology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

Abstract

Tumor cells gain advantages in growth and survival by acquiring genotypic and phenotypic heterogeneity. Interactions with bystander cells in the tumor microenvironment contribute to the progression of heterogeneity. We have shown that fusion between tumor and bystander cells is one form of interaction, and that tumor–bystander cell fusion has contrasting effects. By trapping fusion hybrids in the heterokaryon or synkaryon state, tumor–bystander cell fusion prevents the progression of heterogeneity. However, if trapping fails, fusion hybrids will resume replication to form derivative clones with diverse genomic makeups and behavioral phenotypes. To determine the characteristics of bystander cells that influence the fate of fusion hybrids, we co-cultured prostate mesenchymal stromal cell lines and their spontaneously transformed sublines with LNCaP as well as HPE-15 prostate cancer cells. Subclones derived from cancer–stromal fusion hybrids were examined for genotypic and phenotypic diversifications. Both stromal cell lines were capable of fusing with cancer cells, but only fusion hybrids with the transformed stromal subline generated large numbers of derivative subclones. Each subclone had distinct cell morphologies and growth behaviors and was detected with complete genomic hybridization. The health conditions of the bystander cell compartment play a crucial role in the progression of tumor cell heterogeneity.

Funder

NIH

DoD

Publisher

MDPI AG

Reference45 articles.

1. Molecular heterogeneity in breast cancer: State of the science and implications for patient care;Ellsworth;Semin. Cell Dev. Biol.,2017

2. Tumor heterogeneity;Heppner;Cancer Res.,1984

3. Tumor Heterogeneity—A ‘Contemporary Concept’ Founded on Historical Insights and Predictions;Welch;Cancer Res.,2016

4. The distribution of cellular turnover in the human body;Sender;Nat. Med.,2021

5. Mutator phenotype may be required for multistage carcinogenesis;Loeb;Cancer Res.,1991

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3